Free Newsletter
MIT researchers develop tiny tumor sensor
Researchers at MIT have developed a tiny sensor that can be used to detect changes in tumors. Shaped like a cube measuring 2 millimeters on each side, the device contains nanoparticles that can check for substances linked to tumor growth or for therapies. The nanoparticles can work like a sensor during magnetic resonance imaging. Lead researcher Michael Cima says it's a new and improved way to see if a therapy is actually working, an important part of developing personalized drugs for cancer.
- check out the report on the sensor from the Boston Herald
Related Articles:
Nanoparticles used to destroy tumors. Report
Agent prevents tumors from developing in bones. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




